We are designing a new website for ProCURE, the Program Against Cancer Therapeutic resistance at ICO. It'll have extended information regarding research groups, people, publications, funding, job oportunities and much more. Check it out at www.procure-ico.eu
Great news last week! We got a grant from the Spanish Government through the Carlos II Health Institute to move forward with the epiCRPC project in which we will try to unravel how chromatin accessibility shapes the response to anti-androgen therapies, and in particular whether this is a context dependent phenomenon.